PC
Pablo J Cagnoni (President, R&D) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Incyte Corporation (INCY). The largest single filing was $2.8M of INCY (23,218 sh across 2 lots, as filed), executed Sep 15. Data as of Nov 16 2026.
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
9
0 buys · 9 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$14.4M
shares × price, as filed
Last traded
Oct 15
Filed Oct 19
Median ADV $231.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $14.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
9 filings
Sector per market data · by filing · past 12 months
Most traded names
INCYRecent filings
INCYSALE
Incyte Corporation
View filing →
$298K2,642 sh × $112.71
Exec Oct 15
Filed Oct 19 · 4:38 PM ET INCYSALE Incyte Corporation View filing → $2.8M
23,218 sh across 2 lots
Exec Sep 15
Filed Sep 17 · 4:04 PM ET INCYSALE Incyte Corporation View filing → $1.4M
10,801 sh × $125.56
Exec Aug 19
Filed Aug 20 · 5:15 PM ET INCYSALE Incyte Corporation View filing → $1.3M
10,803 sh × $120.04
Exec Aug 12
Filed Aug 14 · 4:01 PM ET INCYSALE Incyte Corporation View filing → $1.3M
10,640 sh × $122.69
Exec Aug 5
Filed Aug 7 · 4:02 PM ET INCYSALE Incyte Corporation View filing → $1.9M
15,888 sh × $119.70
Exec Jul 31
Filed Aug 4 · 4:04 PM ET INCYSALE Incyte Corporation View filing → $1.8M
18,667 sh × $96.50
Exec Apr 17
Filed Apr 21 · 5:30 PM ET INCYSALE Incyte Corporation View filing → $1.8M
18,667 sh × $94.24
Exec Mar 17
Filed Mar 19 · 5:30 PM ET More filings →